STOCK TITAN

Golden Star Res Financials

GLNS
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE June

This page shows Golden Star Res (GLNS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GLNS FY2025

Reported numbers show a widening balance-sheet shortfall: liabilities expanded much faster than assets, leaving little visible operating cushion.

From FY2023 to FY2025, assets were nearly flat while liabilities moved from $774K to $891K. Because equity was already deeply negative, that added burden made the company look even more creditor-funded without evidence of a meaningfully larger operating base.

A cash uptick from $13 in FY2024 to $45 in FY2025 does not offset a retained deficit of $995K. With diluted EPS still at -$0.01, the filings do not show the business rebuilding its own capital base.

Some figures from recent filings were inconsistent and were omitted from this summary.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Golden Star Res's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
N/A
EPS (Diluted)
$-0.01
YoY+0.0%

Golden Star Res earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$45
YoY+246.2%
5Y CAGR+9.2%
10Y CAGR+4.9%

Golden Star Res held $45 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

GLNS Income Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$14K N/A -$17K N/A -$14K N/A -$14K-12.9% -$13K
EPS (Diluted) $0.00 $0.00 $0.00 N/A $0.00 $0.00 $0.00 N/A

GLNS Balance Sheet

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Total Assets $8K+156.2% $3K-59.6% $7K+147.7% $3K-59.4% $7K+158.9% $3K-60.0% $7K+148.8% $3K
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $450.0% $450.0% $450.0% $45+800.0% $5+150.0% $2 N/A $13
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $943K+2.0% $924K+1.2% $913K+2.4% $891K+1.5% $878K+2.1% $860K+2.3% $840K+2.3% $822K
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$935K-1.5% -$921K-1.7% -$905K-1.9% -$888K-2.0% -$871K-1.6% -$857K-2.8% -$833K-1.8% -$819K
Retained Earnings -$1.0M-1.4% -$1.0M-1.5% -$1.0M-1.7% -$995K-1.8% -$978K-1.4% -$964K-2.5% -$941K-1.6% -$926K

GLNS Financial Ratios

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -187.3% N/A -236.1% N/A -188.4% N/A -206.1%+248.1pp -454.3%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity -1.010.0 -1.000.0 -1.010.0 -1.000.0 -1.010.0 -1.000.0 -1.010.0 -1.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$888K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Golden Star Res (GLNS) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Golden Star Res (GLNS) had $3K in total assets as of fiscal year 2025, including both current and long-term assets.

Golden Star Res (GLNS) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Golden Star Res (GLNS) has negative shareholder equity of -$888K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top